Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum OXiGENE OXGN

"OxiGene Inc is a biopharmaceutical company. The Company is engaged in the development of vascular disrupting agents, or VDAs, for the treatment of cancer. It is currently developing two clinical stage investigational drugs, both VDAs- CA4P and OXi4503."

NDAQ:OXGN - Post Discussion

OXiGENE > OXGN
View:
Post by david39 on Aug 10, 2010 4:37am

OXGN

OXGN broke through two resistance levels on Monday – the first at
.35 and the second at
.40. The price rallied to a high of
.55, which created some profit-taking and it ended the day at
.46. With 4.7 million shares traded during the session, people are expecting to see another strong move today. Yesterday’s closing price represents a good entry point for investors who missed the initial rally.
Comment by thomson25 on Aug 10, 2010 4:58am
OXGN is up at 0.460 cents by 36.09%.
Comment by tonyclark126 on Aug 10, 2010 5:07am
OXGN is going really and I want you to keep it n your watch list.
Comment by mikejohnson21 on Aug 10, 2010 5:17am
OXGN is really flying and I am very bullish on it.
Comment by Jamescarter54 on Aug 10, 2010 5:23am
OXGN is up again so keep an eye on it.